The Online Investor

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Thu., Jan. 20, 11:14 PM

Slide #21. Avenue Therapeutics, Inc. Secondary Offering

Company: Avenue Therapeutics, Inc. (NASDAQ:AXTI)
Date announced: 12/12/2021
Shares Offered: 1,910,100
Date of Pricing: 12/12/2021
Price Per Share: $1.07
Secondary Offering Details: Avenue Therapeutics, Inc. (NASDAQ: ATXI) ("Avenue"), a company focused on the development of intravenous ("IV") tramadol for the U.S. market, today announced the pricing of an underwritten public offering with gross proceeds to the Company expected to be approximately $2.0 million, before deducting underwriting discounts and commissions and other estimated expenses payable by the Company. The offering equates to 1,910,100 shares at a price to the public of $1.07 per share. The Company intends to use the net proceeds from this offering for working capital and general corporate purposes. In addition, the Company granted the underwriters a 45-day option to purchase additional shares of common stock, representing up to 15.0% of the number of the shares, solely to cover over-allotments, if any, which would increase the total gross proceeds of the offering to approximately $2.3 million, if the over-allotment option is exercised in full.

AXT is a materials science company that develops and produces compound and single element semiconductor substrates, also known as wafers. Co.'s compound substrates combine indium with phosphorous (indium phosphide (InP)) or gallium with arsenic (gallium arsenide (GaAs)). Co.'s single element substrates are made from germanium. InP is a semiconductor substrate used in fiber optic lasers and detectors, passive optical networks, telecommunication, silicon photonics, and photonic integrated circuits. Co. makes semi-insulating GaAs substrates used in making semiconductor chips in applications such as power amplifiers for wireless devices, transistors and solar cells for drones.

AXTI SEC Filing Email Alerts Service

Open the AXTI Page at The Online Investor »

Company Name: 
Stock buyback: 
AXTI buyback
Number of ETFs Holding AXTI: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 

Open the AXTI Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree AXTI Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Buy (3.25 out of 4)
30th percentile
(ranked lower than approx. 70% of all stocks covered)

Analysts' Target Price:
AXTI Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings Page |

Copyright © 1998 - 2022, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.